These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7290098)

  • 21. Tests for genotoxicity and mutagenicity of furan and its metabolite cis-2-butene-1,4-dial in L5178Y tk+/- mouse lymphoma cells.
    Kellert M; Brink A; Richter I; Schlatter J; Lutz WK
    Mutat Res; 2008 Dec; 657(2):127-32. PubMed ID: 18804178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutagenicity and toxicity of the DNA alkylation carcinogens 1,2-dimethylhydrazine and azoxymethane in Escherichia coli and Salmonella typhimurium.
    Xiao W; Nowak M; Laferte S; Fontanie T
    Mutagenesis; 1996 May; 11(3):241-5. PubMed ID: 8671746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The induction and characterization of mouse lymphoma L5178Y cell lines resistant to 1-beta-d-arabinofuranosylcytosine.
    Rogers AM; Hill R; Lehmann AR; Arlett CF; Burns VW
    Mutat Res; 1980 Jan; 69(1):139-48. PubMed ID: 7360142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The mutagenicity of 2-amino-N6-hydroxyadenine to L5178Y tk +/- 3.7.2C mouse lymphoma cells: measurement of mutations to ouabain, 6-thioguanine and trifluorothymidine resistance, and the induction of micronuclei.
    Cole J; Richmond FN; Bridges BA
    Mutat Res; 1991 Aug; 253(1):55-62. PubMed ID: 1908053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hamster hepatocyte-mediated activation of procarcinogens to mutagens in the L5178Y/TK mutation assay.
    Amacher DE; Paillet SC
    Mutat Res; 1982 Dec; 106(2):305-16. PubMed ID: 7155171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A statistical method for analysis of mouse lymphoma L5178Y cell TK locus forward mutation assay. Comparison of results among three laboratories.
    Irr JD; Snee RD
    Mutat Res; 1982 Oct; 97(5):371-92. PubMed ID: 7144804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Temperature sensitivity of small-colony TFTres variants of L5178Y mouse lymphoma cells may be due to fastidious growth requirements of macromutations.
    Clive D; Glover PL
    Mutat Res; 1991 Aug; 260(4):401-5, 407. PubMed ID: 1714543
    [No Abstract]   [Full Text] [Related]  

  • 28. Metabolic activation capabilities of S9 liver fraction from 3 species in the L5178Y mouse-lymphoma assay.
    Oberly TJ; Piper CE; McDonald DS
    Mutat Res; 1982 Dec; 105(6):439-44. PubMed ID: 6818472
    [No Abstract]   [Full Text] [Related]  

  • 29. Mutagenicity of three disinfection by-products: di- and trichloroacetic acid and chloral hydrate in L5178Y/TK +/- (-)3.7.2C mouse lymphoma cells.
    Harrington-Brock K; Doerr CL; Moore MM
    Mutat Res; 1998 Mar; 413(3):265-76. PubMed ID: 9651541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The mutagenic activity of selected compounds at the TK locus: rodent vs. human cells.
    Caspary WJ; Langenbach R; Penman BW; Crespi C; Myhr BC; Mitchell AD
    Mutat Res; 1988 Jul; 196(1):61-81. PubMed ID: 3292900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity of bromochlorodifluoromethane (BCF) in three mutation tests.
    Styles JA; Richardson CR; Callander RD; Cross MF; Bennett IP; Longstaff E
    Mutat Res; 1985 Apr; 142(4):187-92. PubMed ID: 3885022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. L5178Y mouse lymphoma cell mutation assay results with 41 compounds.
    Myhr B; McGregor D; Bowers L; Riach C; Brown AG; Edwards I; McBride D; Martin R; Caspary WJ
    Environ Mol Mutagen; 1990; 16 Suppl 18():138-67. PubMed ID: 2128695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mouse lymphoma L5178Y thymidine kinase locus assay of 50 compounds.
    Wangenheim J; Bolcsfoldi G
    Mutagenesis; 1988 May; 3(3):193-205. PubMed ID: 3045481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The tumour promoter TPA does not affect mutation to ouabain resistance in L5178Y mouse lymphoma cells.
    Lasne C; Cole J; Arlett CF
    Carcinogenesis; 1980 Jul; 1(7):627-31. PubMed ID: 11219839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of mutations in mouse lymphoma L5178Y cells by ethylmethanesulphonate, benzidine and benzo[a]pyrene.
    Henderson L; Ransome S; Brabbs C; Tinner A; Davies S
    Mutagenesis; 1990; 5 Suppl():27-34. PubMed ID: 2184317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ethyl methanesulphonate mutagenesis with L5178Y mouse lymphoma cells: a comparison of ouabain, thioguanine and excess thymidine resistance.
    Cole J; Arlett CF
    Mutat Res; 1976 Mar; 34(3):507-25. PubMed ID: 1264112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling the mouse lymphoma forward mutational assay: the Gene-Tox program database.
    Grant SG; Zhang YP; Klopman G; Rosenkranz HS
    Mutat Res; 2000 Feb; 465(1-2):201-29. PubMed ID: 10708987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutagenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin and perfluoro-n-decanoic acid in L5178Y mouse-lymphoma cells.
    Rogers AM; Andersen ME; Back KC
    Mutat Res; 1982 Dec; 105(6):445-9. PubMed ID: 7155164
    [No Abstract]   [Full Text] [Related]  

  • 39. Methyl methanesulphonate mutagenesis in L5178Y mouse lymphoma cells.
    Cole J; Arlett CF
    Mutat Res; 1978 Apr; 50(1):111-20. PubMed ID: 205781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies of an S9-based metabolic activation system used in the mouse lymphoma L5178Y cell mutation assay.
    McGregor DB; Edwards I; Riach CG; Cattanach P; Martin R; Mitchell A; Caspary WJ
    Mutagenesis; 1988 Nov; 3(6):485-90. PubMed ID: 3070287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.